vanda pharmaceuticals inc
Howard H. Pien
Director and Chairman of Compensation Committee, ImmunoGen, Inc.
|Age||Total Calculated Compensation||This person is connected to 47 board members in 6 different organizations across 10 different industries.|
See Board Relationships
Mr. Howard H. Pien serves as an Advisor to the Life Sciences Practice at Warburg Pincus. Mr. Pien served as the Chief Executive Officer and President of Medarex, Inc. from June 14, 2007 to September 2009 and its Chairman of the Board from May 15, 2008 to September 2009. He joined Medarex, Inc. in June 2007. He has over 30 years of pharmaceutical and biotechnology industry experience. Mr. Pien served as the Chief Executive Officer and President of Chiron, Corp. from April ...
2200 Pennsylvania Avenue NWPhone: 202-734-3400
Washington, District Of Columbia 20037
Board Members Memberships*
Former Lead Independent Director and Chairman of Nominating & Corporate Governance Committee
Former Chairman, Chief Executive Officer and Member of Stock Option Plan Administration Committee
Former Chairman of the Board, Chief Executive Officer and President
Director, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee
Director and Chairman of Compensation Committee
Director, Member of Audit Committee and Member of Compensation Committee
Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Director and Member of Audit Committee
Carnegie Mellon University
Massachusetts Institute of Technology
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|Clay B. Siegall Ph.D.||Co-Founder, Chairman, Chief Executive Officer and President|
Seattle Genetics Inc.
|Ian C. Read||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Severin Schwan Ph.D.||Chief Executive Officer and Director|
Roche Holding AG
|SFr.5.1M||Compensation as of Fiscal Year 2013.|